| Pharmaceutical Information |
| Drug Name |
Olsalazine sodium |
| Drug ID |
BADD_D01608 |
| Description |
Olsalazine is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. Olsalazine is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. Mesalamine works as an anti-inflammatory agent in treating inflammatory diseases of the intestines. |
| Indications and Usage |
For the treatment of Inflammatory Bowel Disease and Ulcerative Colitis. |
| Marketing Status |
approved |
| ATC Code |
A07EC03 |
| DrugBank ID |
DB01250
|
| KEGG ID |
D00727
|
| MeSH ID |
C032587
|
| PubChem ID |
135413505
|
| TTD Drug ID |
D00KRE
|
| NDC Product Code |
54864-840; 0037-6860 |
| UNII |
Y7JEW0XG7I
|
| Synonyms |
olsalazine | azodisalicylate | Dipentum | Rasal | olsalazine sodium | disodium 5,5'-azodisalicylate | sodium diazosalicylate | olsalazine, disodium salt | azodisal sodium | disodium azodisalicylate | CJ-91B |
|
| Chemical Information |
| Molecular Formula |
C14H8N2Na2O6 |
| CAS Registry Number |
6054-98-4 |
| SMILES |
C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)[O-])C(=O)O)C(=O)O)[O-].[Na+].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
